Showing results (1-10 of 136) with videos related to
Sort By:
Pageof 14
Hematology/Oncology Clinics of North America|August 31, 2020
Minimal Residual Disease in Mantle Cell Lymphoma: Methods and Clinical SignificanceMarco Ladetto, Rita Tavarozzi, Christiane PottMediterranean Journal of Hematology and Infectious Diseases|May 18, 2017
Infections and Follicular Lymphoma: is there a Link?Francesco Zallio, Giulia Limberti, Marco LadettoMethods in Molecular Biology (Clifton, N.J.)|May 3, 2018
Droplet Digital PCR for Minimal Residual Disease Detection in Mature Lymphoproliferative DisordersDaniela Drandi, Simone Ferrero, Marco LadettoHemasphere|May 9, 2020
Controversies in the Treatment of Follicular LymphomaKai Hübel, Michele Ghielmini, Marco Ladetto, et al.Current Treatment Options in Oncology|November 8, 2018
Minimal Residual Disease in Indolent Lymphomas: A Critical AssessmentDaniele Grimaldi, Elisa Genuardi, Martina Ferrante, et al.Methods in Molecular Medicine|June 22, 2005
Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in myelomaMara Compagno, Barbara Mantoan, Monica Astolfi, et al.Hematological Oncology|March 10, 2010
Telomeres and telomerase in normal and malignant B-cellsChiara Lobetti-Bodoni, Elisa Bernocco, Elisa Genuardi, et al.Bone Marrow Transplantation|August 18, 2018
Methods and role of minimal residual disease after stem cell transplantationMarco Ladetto, Sebastian Böttcher, Nicolaus Kröger, et al.Hematological Oncology|June 9, 2012
Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigmsSimone Ferrero, Daniela Drandi, Barbara Mantoan, et al.Expert Opinion on Pharmacotherapy|April 22, 2024
Pharmacotherapy considerations in patients who develop acute kidney injury during anti-cancer therapyEmanuele Parodi, Maura Rossi, Achille Bottiglieri, et al.Pageof 14